The costs monitor forms a sound basis for every health economic assessment. It calculates the cost of a care pathway where a standard operation determines the null hypothesis. This can then be followed by an assessment of the impact of a new technology, medicine or intervention on the costs and health effects.
Möbius builds the bridge between the pharmaceutical sector and hospitals:
- Möbius offers hospitals insights in the costs of care pathways and provides for this an intuitive dashboard: the costs monitor.
- In collaboration with the hospital, a health economic evaluation of a new technology, medicine or intervention can be conducted.
- The costs monitor dashboard can consequently be utilised to conduct other cost studies.
